Gene · 6372
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. | Nat Immunol | 2022 | 36271146 | PubTator, text mining | PubMed |
| Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia. | Front Cell Dev Biol | 2022 | 36263015 | PubTator, text mining | PubMed |
| Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer. | Int Immunopharmacol | 2022 | 36252470 | PubTator, text mining | PubMed |
| An immunogenic cell death-related regulators classification patterns and immune microenvironment infiltration characterization in intracranial aneurysm based on machine learning. | Front Immunol | 2022 | 36248807 | PubTator, text mining | PubMed |
| Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis. | Biomed Res Int | 2022 | 36246978 | PubTator, text mining | PubMed |
| Investigating the evolution process of lung adenocarcinoma via random walk and dynamic network analysis. | Front Genet | 2022 | 36246662 | PubTator, text mining | PubMed |
Lacticaseibacillus rhamnosus R0011 secretome attenuates Salmonella enterica serovar Typhimurium secretome-induced intestinal epithelial cell monolayer damage and pro-inflammatory mediator production in intestinal epithelial cell and antigen-presenting cell co-cultures. | Front Microbiol | 2022 | 36246229 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone. | Clin Transl Med | 2022 | 36245324 | PubTator, text mining | PubMed |
| The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma. | Clin Transl Med | 2022 | 36245289 | PubTator, text mining | PubMed |
| Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. | Elife | 2022 | 36239699 | PubTator, text mining | PubMed |
| Inflammation-Driven Secretion Potential Is Upregulated in Osteoarthritic Fibroblast-Like Synoviocytes. | Int J Mol Sci | 2022 | 36233118 | PubTator, text mining | PubMed |
| Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study. | Cancers (Basel) | 2022 | 36230498 | PubTator, text mining | PubMed |
| New endoscopic tools in inflammatory bowel disease. | United European Gastroenterol J | 2022 | 36225117 | PubTator, text mining | PubMed |
| Airway surface hyperviscosity and defective mucociliary transport by IL-17/TNF-α are corrected by β-adrenergic stimulus. | JCI Insight | 2022 | 36219481 | PubTator, text mining | PubMed |
| Downregulated PRNP Facilitates Cell Proliferation and Invasion and Has Effect on the Immune Regulation in Ovarian Cancer. | J Immunol Res | 2022 | 36213323 | PubTator, text mining | PubMed |
| Pilot study of peripheral blood chemokines as biomarkers for atrial fibrillation-related thromboembolism and bleeding in elderly patients. | Front Public Health | 2022 | 36211709 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer. | Cell Death Dis | 2022 | 36209194 | PubTator, text mining | PubMed |
| Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. | Cell Discov | 2022 | 36198671 | PubTator, text mining | PubMed |
| Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma. | BMC Cancer | 2022 | 36195857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6372/papers?page=37